Elme Communities Common Stock (ELME)
17.20
+0.09 (0.56%)
NYSE · Last Trade: Dec 10th, 3:42 PM EST
IRT’s fundamentals may be sturdier than its stock chart suggests — and one fund is making a sizable bet on that gap closing.
Via The Motley Fool · December 9, 2025
One REIT is quietly improving its fundamentals far faster than its stock price reflects — but big money is still trimming.
Via The Motley Fool · December 9, 2025
A beaten-down REIT just raised guidance — here’s why one fund decided it was the right moment to jump in.
Via The Motley Fool · December 9, 2025

Via Benzinga · March 14, 2024
ELME Communities (ELME) Q3 2025 earnings beat EPS estimates but revenue slightly missed. The stock showed muted reaction to the mixed results.
Via Chartmill · October 23, 2025
Via Benzinga · September 11, 2025
Elme Communities (NYSE:ELME) posted mixed Q2 2025 results, with EPS beating estimates but revenue slightly missing. Shares dipped in after-hours trading amid investor caution.
Via Chartmill · August 5, 2025

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via Benzinga · February 15, 2024

Via Benzinga · September 14, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Via Benzinga · February 16, 2023
Via Benzinga · March 13, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 5, 2025

Although passive income is important, you don’t have to pay “full retail” as these low-cost dividend stocks confirm.
Via InvestorPlace · May 9, 2024

ELME stock results show that Elme Communities beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
Via Benzinga · June 2, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via Benzinga · July 31, 2023


